119 related articles for article (PubMed ID: 7251472)
41. Preparation and evaluation of 3,4''-ester derivatives of 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Debono M; Willard KE; Truedell BA; Toth JE; Turner JR; Berry DR; Briggs BB; Fukuda DS; Daupert VM
J Antibiot (Tokyo); 1986 Dec; 39(12):1724-35. PubMed ID: 3818446
[TBL] [Abstract][Full Text] [Related]
42. Properties of midecamycin, a new macrolide antibiotic.
Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
[No Abstract] [Full Text] [Related]
43. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
[TBL] [Abstract][Full Text] [Related]
44. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
[TBL] [Abstract][Full Text] [Related]
45. [Studies on acetyl-spiramycin in gynecology and obstetrics].
Cho N; Nohara S; Sunada H; Sugiyama S; Kunii K
J Antibiot B; 1966 Jun; 19(3):211-6. PubMed ID: 5298424
[No Abstract] [Full Text] [Related]
46. [Curative activity of spiramycin adipate by parenteral route in experimental septicemia in mice. Comparison with orally administered basic spiramycin].
Rolin O; Bouveret E; Bouanchaud DH
Pathol Biol (Paris); 1986 May; 34(5):476-8. PubMed ID: 3534725
[TBL] [Abstract][Full Text] [Related]
47. Preliminary clinical pharmacological investigations of tylosin and tiamulin in chickens.
Ziv G
Tijdschr Diergeneeskd; 1980 Oct; 105(20):206-10. PubMed ID: 7444918
[TBL] [Abstract][Full Text] [Related]
48. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
Brook I
J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
[TBL] [Abstract][Full Text] [Related]
49. Effects of tylosin feeding on the antibiotic resistance of selected gram-positive bacteria in pigs.
Christie PJ; Davidson JN; Novick RP; Dunny GM
Am J Vet Res; 1983 Jan; 44(1):126-8. PubMed ID: 6824216
[TBL] [Abstract][Full Text] [Related]
50. [Ophthalmological application of acetyl spiramycin].
Mikuni M; Oishi M; Hashi H; Shuda S; Imai M
J Antibiot B; 1966 Dec; 19(6):447-54. PubMed ID: 5298393
[No Abstract] [Full Text] [Related]
51. The effect of antibiotics against bovine mycoplasmas and ureaplasmas.
Truscott RB; Ruhnke HL
Can J Comp Med; 1984 Apr; 48(2):171-4. PubMed ID: 6232992
[TBL] [Abstract][Full Text] [Related]
52. [Experimental study on the antistaphylococcal activity of acetyl-spiramycin].
Kawamori Y; Tanaka S; Tomimatsu S
J Antibiot B; 1967 Feb; 20(1):10-1. PubMed ID: 5299296
[No Abstract] [Full Text] [Related]
53. [Annual changes in susceptibility of clinical isolates to midecamycin acetate].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Aug; 43(8):1341-52. PubMed ID: 2283704
[TBL] [Abstract][Full Text] [Related]
54. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
55. In vitro activity of tiamulin against porcine mycoplasmas.
Goodwin RF
Res Vet Sci; 1985 Jan; 38(1):124-5. PubMed ID: 3975477
[TBL] [Abstract][Full Text] [Related]
56. Modifications of a macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetylmidecamycin with dimethylsulfoxide and acetic anhydride.
Inouye S; Omoto S; Iwamatsu K; Niida T
J Antibiot (Tokyo); 1980 Jan; 33(1):61-71. PubMed ID: 7372551
[TBL] [Abstract][Full Text] [Related]
57. Chemical transformation of tylosin, a 16-membered macrolide, and its structure-activity relationship.
Matsubara H; Miyano K; Nakagawa A; Omura S
Chem Pharm Bull (Tokyo); 1982 Jan; 30(1):97-110. PubMed ID: 7083417
[No Abstract] [Full Text] [Related]
58. [In vitro susceptibility of Mycoplasma gallisepticum field strains to tiamulin and tylosin (author's transl)].
Hinz KH
Dtsch Tierarztl Wochenschr; 1980 Jun; 87(6):220-3. PubMed ID: 6995088
[No Abstract] [Full Text] [Related]
59. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
[TBL] [Abstract][Full Text] [Related]
60. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
